Does Psychological Stress Affect the Progression of Parkinson’s Disease (N5.002)
Abstract
Objective:
To examine the relationship between psychological stress and Parkinson’s disease progression.
Background:
Animal studies suggest that Parkinson’s disease (PD) pathology is negatively affected by stress. More stressful life events may increase the risk of PD. Stress increases damage to dopamine cells and results in more severe parkinsonian symptoms in animal studies. In humans, acute stress can worsen bradykinesia, motor blocking (freezing), and tremor and it is hypothesized that stress may negatively affect dopamine synthesis and release.
Design/Methods:
Data from the National Parkinson’s Foundation Quality Improvement Initiative (NPF-QII) was analyzed. The design, data collection, and approach to case-mix adjustment for the study has been described previously (Okun, 2011). All NPF-QII participants able to walk unassisted at baseline were included. A stress proxy score (derived from PDQ-39 and MCSI), a mobility proxy score (derived from iTUG and PDQ-39), and an overall health status score (derived from PDQ-39, falls score, hospital admissions, and cognitive score) were calculated for each subject (n=4,155). Excess stress was identified as positive deviation from the linear regression between the stress proxy score and a normalized combination of the other outcomes measured (motor, cognitive, falls, and other PDQ-39 domains). This “excess stress” (ES) score reflects the emotional stress above that typically resulting from disease severity or overall health.
Results:
1) The stress proxy score predicts mortality but the ES score does not (p<0.001). 2) high baseline stress proxy score predicts worsening mobility on follow-up (p<0.001; R2=0.026), and high ES also predicts worsening mobility (p=0.0014; R2=0.0025).
Conclusions:
Stress may be a modifiable risk factor for disease progression.
Study Supported by: National Parkinson Foundation
Disclosure: Dr. Hiller has nothing to disclose. Dr. Quinn has received personal compensation for activities with Novartis as a speaker. Dr. Schmidt has nothing to disclose.
Information & Authors
Information
Published In
Neurology®
Volume 88 • Number 16_supplement • April 18, 2017
Copyright
© 2017.
Publication History
Published online: April 18, 2017
Published in issue: April 18, 2017
Authors
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- The challenges in managing co-occurring Parkinson's and schizophrenia spectrum disorders, British Journal of Nursing, 32, 20, (996-1002), (2023).https://doi.org/10.12968/bjon.2023.32.20.996
- Neuropsychiatric Burden Is a Predictor of Early Freezing and Motor Progression in Drug-Naïve Parkinson’s Disease, Journal of Parkinson's Disease, 11, 4, (1947-1956), (2021).https://doi.org/10.3233/JPD-212660
- SFPQ and Tau: critical factors contributing to rapid progression of Alzheimer’s disease, Acta Neuropathologica, 140, 3, (317-339), (2020).https://doi.org/10.1007/s00401-020-02178-y
- Prognostic factors of Rapid symptoms progression in patients with newly diagnosed parkinson’s disease, Artificial Intelligence in Medicine, 103, (101807), (2020).https://doi.org/10.1016/j.artmed.2020.101807
Loading...
View Options
View options
PDF and All Supplements
Download PDF and Supplementary MaterialLogin options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.